Cargando…

What is the performance of the Aspartate Aminotransferase to platelets Ratio Index in patients With Chronic Liver Disease?

Detalles Bibliográficos
Autor principal:	Zarski, Jean Pierre
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Kowsar 2011
Materias:	Letter to Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3282024/ https://www.ncbi.nlm.nih.gov/pubmed/22368686 http://dx.doi.org/10.5812/kowsar.1735143X.798

Ejemplares similares

Aspartate aminotransferase to platelet ratio index for the assessment of liver fibrosis severity in patients with chronic hepatitis
por: Sirli, Roxana, et al.
Publicado: (2011)

Is the aspartate transaminase to platelet ratio index adequate for the assessment of liver fibrosis in patients with chronic liver disease?
por: Parsian, Hadi
Publicado: (2011)

Aspartate transaminase to platelet ratio index (APRI) to assess liver fibrosis in patients with chronic liver disease
por: Anania, Caterina, et al.
Publicado: (2011)

Aspartate aminotransferase-platelet ratio index, adiponectin and body mass index in children with fatty liver
por: Kusumawati, Ninung RD, et al.
Publicado: (2013)

Noninvasive assessment of liver fibrosis with aspartate transaminase to platelet ratio index (APRI)
por: Adler, Michael
Publicado: (2011)

Commentary on: Aspartate transaminase to platelet ratio index (APRI): A simple noninvasive index assessing liver fibrosis in patients with chronic liver diseases
por: Mao, Yilei, et al.
Publicado: (2011)

Commentary on: Noninvasive assessment of liver fibrosis using aspartate transaminase to platelet ratio index (APRI) in adult patients with chronic liver disease
por: El-Shabrawi, Mortada, et al.
Publicado: (2011)

The aspartate aminotransferase-to-platelet ratio and the evaluation of non-alcoholic fatty liver disease
por: Tapper, Elliot B.
Publicado: (2014)

Postoperative aspartate aminotransferase to platelet ratio index change predicts prognosis for hepatocellular carcinoma
por: Peng, Wei, et al.
Publicado: (2016)

Macro-aspartate aminotransferase in a healthy woman
por: Lorubbio, Maria, et al.
Publicado: (2020)

Comparison of FIB-4 index and aspartate aminotransferase to platelet ratio index on carcinogenesis in chronic hepatitis B treated with entecavir
por: Nishikawa, Hiroki, et al.
Publicado: (2017)

Preoperative aspartate aminotransferase-to-platelet-ratio index as a predictor of posthepatectomy liver failure for resectable hepatocellular carcinoma
por: Mai, Rong-Yun, et al.
Publicado: (2019)

Is aspartate aminotransferase-to-platelet ratio index a biomarker in the evaluation of advanced fibrosis in non-alcoholic fatty liver disease?
por: Agilli, Mehmet, et al.
Publicado: (2014)

Indirect markers of fibrosis in chronic liver diseases: Is aspartate transaminase-to-platelet ratio (APRI) a useful test?
por: Corte, Claudia Della, et al.
Publicado: (2011)

Aspartate aminotransferase-to-platelet ratio index can predict the outcome in patients with stable decompensated cirrhosis
por: Oikonomou, Theodora, et al.
Publicado: (2023)

Impact of aspartate aminotransferase–to–platelet ratio index based score to assess posthepatectomy liver failure in patients with hepatocellular carcninoma
por: Yugawa, Kyohei, et al.
Publicado: (2022)

Preoperative Risk Stratification in Arthroscopic Rotator Cuff Repair: Aspartate Aminotransferase-to-Platelet Ratio Index as an Estimate of Liver Dysfunction
por: Liu, Steven H, et al.
Publicado: (2023)

Ambulatory end-stage liver disease in Ghana; patient profile and utility of alpha fetoprotein and aspartate aminotransferase: platelet ratio index
por: Nartey, Yvonne Ayerki, et al.
Publicado: (2020)

Aspartate Aminotransferase to Platelet Ratio Index and Fibrosis-4 Index for Detecting Liver Fibrosis in Patients With Autoimmune Hepatitis: A Meta-Analysis
por: Dong, Bingtian, et al.
Publicado: (2022)

Use of aspartate aminotransferase to platelet ratio to reduce the need for FibroScan in the evaluation of liver fibrosis
por: Wong, Stephanie, et al.
Publicado: (2017)

Clinicopathological correlation of aspartate aminotransferase-to-platelet ratio (APRI) and aspartate aminotransferase-to-alanine aminotransferase ratio (AAR) with survival in esophageal carcinoma patients: a retrospective cohort analysis of 951 patients
por: Zafar, Muhammad Talha, et al.
Publicado: (2023)

Preoperative aspartate aminotransferase-to-platelet ratio index (APRI) is a predictor on postoperative outcomes of hepatocellular carcinoma
por: Cheng, JiWen, et al.
Publicado: (2016)

Can first-trimester aspartate aminotransferase/platelet ratio index score predict intrahepatic cholestasis of pregnancy?
por: Gok, Koray, et al.
Publicado: (2023)

Increased preoperative aspartate aminotransferase-to-platelet ratio index predicts complications following total shoulder arthroplasty
por: Liu, Steven H., et al.
Publicado: (2023)

The role of preoperative aspartate aminotransferase-to-platelet ratio index in predicting complications following total hip arthroplasty
por: McLellan, M. A., et al.
Publicado: (2023)

Aspartate aminotransferase/alanine aminotransferase ratio and subsequent cancer development
por: Kobayashi, Daiki, et al.
Publicado: (2021)

Diagnostic value of FIB-4, aspartate aminotransferase-to-platelet ratio index and liver stiffness measurement in hepatitis B virus-infected patients with persistently normal alanine aminotransferase
por: Tan, You-Wen, et al.
Publicado: (2017)

The efficacy of aspartate aminotransferase-to-platelet ratio index for assessing hepatic fibrosis in childhood nonalcoholic steatohepatitis for medical practice
por: Kim, Earl, et al.
Publicado: (2013)

Usefulness of aspartate aminotransferase to platelet ratio index as a prognostic factor following hepatic resection for hepatocellular carcinoma
por: Matsumoto, Michinori, et al.
Publicado: (2018)

Aspartate aminotransferase-to-platelet ratio index predicts prognosis of hepatocellular carcinoma after postoperative adjuvant transarterial chemoembolization
por: Zhu, Gui-Qi, et al.
Publicado: (2018)

Relationship Between Aspartate Aminotransferase-to-Platelet Ratio Index and Carotid Intima-Media Thickness in Obese Adolescents with Non-Alcoholic Fatty Liver Disease
por: Sert, Ahmet, et al.
Publicado: (2013)

Aspartate aminotransferase: A prognostic marker rather than a specific liver injury marker in COVID-19
por: Li, Gerui
Publicado: (2020)

Prediction of the Risk of Hepatocellular Carcinoma in Chronic Hepatitis C Patients after Sustained Virological Response by Aspartate Aminotransferase to Platelet Ratio Index
por: Lee, Keol, et al.
Publicado: (2016)

Optimized cutoffs of gamma‐glutamyl transpeptidase‐to‐platelet ratio, aspartate aminotransferase‐to‐platelet ratio index, and fibrosis‐4 scoring systems for exclusion of cirrhosis in patients with chronic hepatitis B
por: Liu, Xiaoqing, et al.
Publicado: (2022)

Validation of Dynamic Aspartate‐to–Alanine Aminotransferase Ratio for Predicting Liver Disease Mortality
por: Song, In‐Ae, et al.
Publicado: (2021)

Comparison of patients using lamivudine, entecavir, and tenofovir according to liver fibrosis markers fibrosis-4 and aspartate aminotransferase-to-platelet ratio index scores
por: Okan, Huseyin Dogus, et al.
Publicado: (2023)

Aspartate aminotransferase to platelet ratio can reduce the need for transient elastography in Chinese patients with chronic hepatitis B
por: Yue, Wei, et al.
Publicado: (2019)

Association between Aspartate Aminotransferase-to-Platelet Ratio Index and Hepatocellular Carcinoma Risk in Patients with Chronic Hepatitis: A Meta-Analysis of Cohort Study
por: Zhang, Chuanmeng, et al.
Publicado: (2019)

Diagnostic accuracy of the aspartate aminotransferase-to-platelet ratio index for the prediction of hepatitis B-related fibrosis: a leading meta-analysis
por: Jin, Wenwen, et al.
Publicado: (2012)

Prognostic value of aspartate aminotransferase to platelet ratio index as a noninvasive biomarker in patients with hepatocellular carcinoma: a meta-analysis
por: Zhang, Yi, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_lhcujc5ijtbngelamieoukcjbu